Published in Cell Death Differ on January 01, 2008
Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ (2008) 1.84
Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol (2011) 1.11
Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts. Breast Care (Basel) (2011) 0.95
Concomitant targeting of tumor cells and induction of T-cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer. Cancer Res (2012) 0.90
Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J Immunol (2014) 0.87
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy. Nat Commun (2014) 0.87
Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy. Semin Immunopathol (2011) 0.78
Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer Therapy. Int J Biol Sci (2016) 0.77
Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (1999) 14.41
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med (2001) 5.71
Molecular mechanisms of cisplatin resistance. Oncogene (2011) 5.20
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature (2001) 5.07
Organelle-specific initiation of cell death pathways. Nat Cell Biol (2001) 5.03
Mitochondrial control of nuclear apoptosis. J Exp Med (1996) 5.01
Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med (1999) 4.92
Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol (2000) 4.89
Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med (1995) 4.88
Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol (1999) 4.87
Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science (1998) 4.84
Lysosomal membrane permeabilization in cell death. Oncogene (2008) 4.40
Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med (1995) 4.20
Regulation of autophagy by the inositol trisphosphate receptor. Cell Death Differ (2007) 4.12
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med (1996) 4.00
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med (1995) 3.67
The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol (2001) 3.66
Chloromethyl-X-Rosamine is an aldehyde-fixable potential-sensitive fluorochrome for the detection of early apoptosis. Cytometry (1996) 3.45
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Cell death modalities: classification and pathophysiological implications. Cell Death Differ (2007) 3.19
Mechanisms of cytochrome c release from mitochondria. Cell Death Differ (2006) 3.13
Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol (2001) 3.05
Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis. Oncogene (2007) 2.85
Two distinct pathways leading to nuclear apoptosis. J Exp Med (2000) 2.84
Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ (2008) 2.84
The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med (1997) 2.83
Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med (1999) 2.79
Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene (2009) 2.74
Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis (2010) 2.69
Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J (2000) 2.65
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med (2000) 2.62
The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol (1998) 2.60
Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis. Cell Death Differ (2007) 2.58
Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun (2001) 2.56
The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med (1998) 2.51
Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med (1996) 2.39
Apoptosis in yeast: triggers, pathways, subroutines. Cell Death Differ (2010) 2.34
The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ (2009) 2.29
NADH oxidase activity of mitochondrial apoptosis-inducing factor. J Biol Chem (2001) 2.22
Cross talk between apoptosis and autophagy by caspase-mediated cleavage of Beclin 1. Oncogene (2010) 2.15
Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med (2001) 2.07
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ (2008) 2.01
Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta (1998) 1.97
Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst (2000) 1.95
Molecular characteristics of immunogenic cancer cell death. Cell Death Differ (2007) 1.92
Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene (2011) 1.87
Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ (1999) 1.84
Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene (2006) 1.83
Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood (1995) 1.83
Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett (2000) 1.82
Apoptosis. Mitochondria--the death signal integrators. Science (2000) 1.81
No death without life: vital functions of apoptotic effectors. Cell Death Differ (2008) 1.80
Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ (2006) 1.77
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene (2010) 1.75
Metacaspases are caspases. Doubt no more. Cell Death Differ (2010) 1.74
Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ (2002) 1.72
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival. Ann Oncol (2013) 1.65
GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene (2006) 1.65
Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic. Cell Death Differ (2002) 1.64
Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol (1996) 1.64
Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death Differ (2013) 1.64
Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J (2001) 1.64
Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ (2004) 1.64
Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ (2000) 1.64
Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med (2006) 1.63
Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ (2009) 1.62
Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene (2000) 1.61
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene (2008) 1.60
Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J Exp Med (2000) 1.59
Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ (2009) 1.58
Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett (1996) 1.58
Illicit survival of cancer cells during polyploidization and depolyploidization. Cell Death Differ (2010) 1.57
The mitochondrion in cell death control: certainties and incognita. Exp Cell Res (2000) 1.54
The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene (1997) 1.53
Mitochondria and programmed cell death: back to the future. FEBS Lett (1996) 1.52
New EMBO members' review: viral and bacterial proteins regulating apoptosis at the mitochondrial level. EMBO J (2001) 1.52
Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ (2005) 1.52
Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes. Immunol Lett (1998) 1.51
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death Differ (2013) 1.49
Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition. FEBS Lett (1998) 1.49
Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene (1998) 1.47
Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med (2001) 1.47
Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene (2000) 1.45
Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study. Oncogene (2011) 1.43
The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene (2001) 1.42
Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ (2002) 1.42
BH3 mimetics activate multiple pro-autophagic pathways. Oncogene (2011) 1.41
Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J Biol Chem (1998) 1.41
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J Clin Invest (1997) 1.39
Targeting NF-kappaB in hematologic malignancies. Cell Death Differ (2006) 1.38
Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death Differ (2000) 1.36
Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J Bioenerg Biomembr (1997) 1.36